Skip to main content
. 2021 Jun 17;11:652193. doi: 10.3389/fonc.2021.652193

Figure 1.

Figure 1

Genetic characteristics of micropapillary component (MPC)-containing tumors within the discovery cohort. (A) Genetic alteration profile of 43 MPC patients whose tumors were micro-dissected based on histologic subtypes and MPC content, including high MPC (30–100% of the original tumor), low MPC (0–20% of the original tumor), and the matched non-MPC regions. (B, C) The trend of tumor mutation burdens (TMB) (B) or chromosome instability score (CIS) (C) ranging from high MPC tumors, low MPC tumors, the matched non-MPC tumors to the reference LADC tumors.